Boston Scientific has grown revenue 16% a year over three years and 13% a year over five, with earnings per share compounding at 60%. Revenue growth, 3-year annual rate: +16% (Medical Devices median +9.2%). Revenue growth, 5-year rate: +13%, growth has picked up over the last three years. Earnings per share, 3-year rate: +60%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 19, FY2007 to FY2025, as filed.

BSXBoston Scientific

HealthcareUSD

$48.18

$42.6452 weeks$108.14

Is it growing?

Is BSX growing?

Boston Scientific has grown revenue 16% a year over three years and 13% a year over five, with earnings per share compounding at 60%.

+16%

Revenue growth, 3-year annual rate · Medical Devices median +9.2% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +13%
Revenue growth, 5-year rate · +16% over three · growth has picked up over the last three years
Earnings per share, 3-year rate: +60%
Earnings per share, 3-year rate · revenue +16% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 19
Years of annual history on file · FY2007 to FY2025, as filed